Is there any place for PD-1/CTLA-4 inhibitors combination in the first-line treatment of advanced NSCLC?—a trial-level meta-analysis in PD-L1 selected subgroups
暂无分享,去创建一个
A. Russo | V. Bazan | F. Passiglia | M. Castiglia | V. Gristina | A. Galvano | M. La Mantia | N. Barraco | A. Perez